Point-of-Care Infectious Disease Diagnostics Market – Global Industry Analysis 2024

Point of care infectious disease diagnostics market has grown manifold in last 20 years driving huge profits across value chains. The industry witnessed staggering growth in-between 2005 to 2010 before taking a major leap with adoption of mobile technology. Point-of-care testing or bed-side testing refers to those tests which are performed near the site of patient care. These tests can potentially improve the detection and management of infectious diseases by reducing the time between tests and results. These testing aids in the reduction of operating times, postoperative care time and high-dependency, thereby ensuring optimal use of professional time. Urine test strips and imaging tests such as portable ultrasound and ECG tests are some examples of point of care testing. Point-of-care testing for infectious diseases includes rapid, reliable and affordable tests for HIV infection, malaria, dengue fever, hepatitis, influenza and pneumonia. Point-of-testing for infectious diseases exhibit a massive opportunity for pharmacy services regarding expansion. Improvement in disease outcome, simple and accurate tests, and rapid disease outcome and results are few of the advantages of point-of-care testing.

Get FREE Sample Of This Research Report: https://www.coherentmarketinsights.com/insight/request-discount/63

The billion dollar point of care infectious disease diagnostic market is expected to grow at a substantial rate over the forecast period.

Advancement in molecular diagnostics coupled with miniaturization of devices to drive the point of care infectious disease diagnostics market

Advancement in technological molecular diagnostics has boosted point of care solutions. Furthermore, the industry is also expected to grow with changing lifestyle. Currently, over 60% of population uses mobile phone. As a result, whole healthcare system has changed wherein portable devices has taken a key place.

Furthermore, growing personalized medicine will create lucrative opportunity for point of care testing market.

Market Taxonomy:
Coherent Market Insights has segmented the point of care infectious disease diagnostics products market by
Therapeutic application
End-users

Based on type of diseases, the point-of-care infectious disease diagnostics
market can be segmented as follows:
HIV/AIDS
Typhoid
Tuberculosis
Pneumonia
Malaria
Influenza
Hepatitis
Cholera
Others

Based on end-users, the point-of-care infectious disease diagnostics market can be segmented as follows:
Hospitals
Laboratories
Clinics
Home-setting
Others
North America is the leading market for point of care infectious disease diagnostics product

Based on geography, the point-of-care infectious disease diagnostics market can be segmented into four major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America holds a leading position in the market followed by Europe. The prime factors which are responsible for the growth of point-of-care infectious disease diagnostics market in these regions are rapidly increasing prevalence of infectious diseases, and growing demand for rapid and accurate test results. According to the National Ambulatory Medical Care Survey, the number of visits to physician offices for infectious and parasitic diseases was recorded to be around 23.6 million in 2010. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period due to presence of a large population base. The factors which would accentuate the growth of point-of-care infectious disease diagnostics market in Asia Pacific are increased funding from the government towards the development of point-of-care diagnostic kits and rapidly changing healthcare infrastructure in emerging countries such as China, India, Vietnam, Malaysia, Indonesia, etc. In addition, reduction in the number of hospital bed required, reduction in the number of outpatient clinic visits, and lesser patient waiting times are few of the potential factors which would propel the growth of point-of-care infectious disease diagnostics market in Asia Pacific during the forecast period.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/point-of-care-infectious-disease-diagnostics-market-63

Abbott Laboratories, Roche Diagnostics Ltd are driving market expansion through high R&D spending along with direct distribution channel in emerging regions

The point-of-care infectious disease diagnostics market is driven by technological advancements and hence, various companies are continuously making efforts to develop novel products pertaining to infectious disease diagnostics. Some of the top companies operating in the point-of-care infectious disease diagnostics market are Abbott Laboratories, Roche Diagnostics Ltd., Beckman Coulter, Inc., Bayer AG, Becton Dickinson and Company, Johnson and Johnson, Alere Inc., Nipro Diagnostics Inc., Nova Biomedical, Siemens AG, Trinity Biotech PLC, Danaher Corporation, Spectral Diagnostics, and others.

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

CORPORATE OFFICE :
Coherent Market Insights
303, Astral Court,Above Reliance Fresh,
Near Gaikwad Petrol Pump,
Aundh, Pune – 411045, India
Mail Id : sales@coherentmarketinsights.com
Visit Blog : http://globalresearchtrends.blogspot.in/

This release was published on openPR.